A high frequency of BRCA mutations in young black women with breast cancer residing in Florida (Q36338690)

13 August 2017

A high frequency of BRCA mutations in young black women with breast cancer residing in Florida (English)

1 reference

13 August 2017

0 references

8

Steven A Narod

1 reference

13 August 2017

4

Alvaro N A Monteiro

1 reference

13 August 2017

5

Catherine Phelan

1 reference

13 August 2017

Tuya Pal

1

1 reference

13 August 2017

Devon Bonner

2

1 reference

13 August 2017

Deborah Cragun

3

1 reference

13 August 2017

Lily Servais

6

1 reference

13 August 2017

Jongphil Kim

7

1 reference

13 August 2017

Mohammad R Akbari

9

1 reference

13 August 2017

Susan T Vadaparampil

10

1 reference

13 August 2017

language of work or name

English

0 references

publication date

19 August 2015

1 reference

13 August 2017

1 reference

13 August 2017

121

1 reference

13 August 2017

23

1 reference

13 August 2017

4173-4180

1 reference

TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666784

Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666784

Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666784

Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666784

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666784

The prevalence of BRCA1 mutations among young women with triple-negative breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666784

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666784

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666784

The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666784

High prevalence of triple-negative tumors in an urban cancer center

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666784

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666784

Disparities in genetic testing: thinking outside the BRCA box.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666784

Breast cancer in African-American women

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666784

Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666784

Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666784

High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666784

Recruitment of black women for a study of inherited breast cancer using a cancer registry-based approach

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666784

Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666784

Clinical significance of large rearrangements in BRCA1 and BRCA2.

22 September 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29645

Prevalence and Predictors ofBRCA1andBRCA2Mutations in a Population-Based Study of Breast Cancer in White and Black American Women Ages 35 to 64 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29645

Racial and Ethnic Disparities in Awareness of Genetic Testing for Cancer Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29645

Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29645

7 January 2021

Frequency of breast cancer attributable to BRCA1 in a population-based series of American women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29645

7 January 2021

Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29645

7 January 2021

Strategies for recruitment of relatives of BRCA mutation carriers to a genetic testing program in the Bahamas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29645

7 January 2021

A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29645

7 January 2021

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26287763

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1002/CNCR.29645

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

26287763

1 reference